AquaBounty Narrows Losses Amid Asset Sales, Going Concern Looms

TL;DR

AquaBounty is selling off its core assets to stay afloat, but without a clear path to profitability, this stock is a speculative bet on a turnaround that looks increasingly unlikely.

AI Summary

AquaBounty Technologies Inc. (AQB) reported a net loss of $1.38 million for the three months ended September 30, 2025, a significant improvement from the $3.40 million net loss in the same period of 2024. For the nine months ended September 30, 2025, the net loss was $4.35 million, a substantial reduction from the $65.08 million net loss in the prior year, primarily due to a $2.01 million loan forgiveness and significantly lower asset impairment charges. The company's revenue remains negligible, with total costs and expenses decreasing to $1.48 million for the quarter from $1.62 million year-over-year. Cash and cash equivalents increased to $951,434 as of September 30, 2025, from $230,362 at December 31, 2024, largely driven by $7.11 million in proceeds from asset sales, including the Indiana Farm in July 2024 and Canadian Farms in March 2025. The company continues to face a going concern uncertainty, having incurred cumulative net losses of $374 million since inception, and is actively seeking new investment or strategic options for its remaining Ohio Farm Project assets.

Why It Matters

AquaBounty's continued net losses and reliance on asset sales for liquidity raise significant concerns for investors, highlighting the company's struggle to achieve commercial viability in the genetically engineered salmon market. The sale of key assets like the Indiana and Canadian farms, along with intellectual property, indicates a strategic pivot away from large-scale RAS farm operations, potentially impacting future growth prospects and competitive positioning against traditional aquaculture and other alternative protein companies. Employees face uncertainty given the company's going concern warning and the pause in the Ohio Farm Project. Customers might see shifts in product availability or pricing as AquaBounty re-evaluates its operational footprint. The broader market will watch if AquaBounty can secure new funding or partnerships to capitalize on its remaining Ohio Farm Site, or if its innovative GE Atlantic salmon technology will ultimately fail to scale commercially.

Risk Assessment

Risk Level: high — The company explicitly states a "Going Concern Uncertainty" due to cumulative net losses of $374 million and only $951,434 in cash as of September 30, 2025. Its ability to continue is dependent on raising additional capital or selling assets, with no assurance of success, indicating a high risk of financial distress.

Analyst Insight

Investors should exercise extreme caution and consider divesting, as the company's going concern warning and reliance on asset sales for survival signal significant financial instability. Await concrete evidence of successful new investment or a viable strategic partnership for the Ohio Farm Project before considering any new positions.

Financial Highlights

debt To Equity

0.97

revenue

Not explicitly stated, but negligible

operating Margin

N/A

total Assets

$24,173,791

total Debt

$7,910,684

net Income

-$1.38M

eps

N/A

gross Margin

N/A

cash Position

$951,434

revenue Growth

N/A

Key Numbers

• $1.38M — Net Loss (Q3 2025) (Reduced from $3.40M in Q3 2024)
• $4.35M — Net Loss (YTD Q3 2025) (Significantly reduced from $65.08M in YTD Q3 2024)
• $951,434 — Cash and Cash Equivalents (Sept 30, 2025) (Increased from $230,362 at Dec 31, 2024, but still very low)
• $374M — Cumulative Net Losses (Since inception, indicating ongoing financial challenges)
• $7.11M — Proceeds from Asset Sales (YTD Q3 2025) (Primary source of cash inflow, including Indiana and Canadian Farms)
• $2.01M — Loan Forgiveness (YTD Q3 2025) (Contributed to reduced net loss)
• $1.48M — Total Costs and Expenses (Q3 2025) (Decreased from $1.62M in Q3 2024)
• 3,877,695 — Common Shares Outstanding (Oct 28, 2025) (Reflects current share count)

Key Players & Entities

• AquaBounty Technologies Inc. (company) — registrant
• NASDAQ Stock Market LLC (regulator) — exchange where common stock is registered
• SEC (regulator) — Securities and Exchange Commission
• Financial Accounting Standards Board (regulator) — issued ASU No. 2024-03
• Indiana Farm (company) — grow-out farm sold in July 2024
• Canadian Farms (company) — broodstock farms sold in March 2025
• Ohio Farm Project (company) — primary remaining asset, construction paused
• GE Atlantic salmon (company) — genetically engineered Atlantic salmon product

FAQ

Risk Factors

• Going Concern Uncertainty [high — financial]: The company has incurred cumulative net losses of $374 million since inception and has a history of significant operating losses. This raises substantial doubt about its ability to continue as a going concern. The company is actively seeking new investment or strategic options for its remaining Ohio Farm Project assets to address this uncertainty.
• Dependence on Asset Sales for Liquidity [medium — financial]: The company's cash position increased to $951,434 as of September 30, 2025, primarily due to $7.11 million in proceeds from asset sales, including the Indiana and Canadian Farms. This reliance on asset sales for liquidity indicates a potential vulnerability if future asset sales are not successful or generate insufficient proceeds.
• Limited Revenue Generation [high — operational]: AquaBounty Technologies Inc. continues to report negligible revenue. For the three months ended September 30, 2025, revenue was not explicitly stated but implied to be minimal given the total costs and expenses of $1.48 million and a net loss of $1.38 million. This lack of substantial revenue generation hinders profitability and self-sustainability.
• High Operating Costs Relative to Revenue [medium — financial]: Despite a reduction in total costs and expenses to $1.48 million for Q3 2025 from $1.62 million in Q3 2024, these costs remain significantly higher than the company's revenue. The company reported a net loss of $1.38 million for Q3 2025, underscoring the challenge of covering operational expenses with current income.
• Significant Reduction in Assets [medium — financial]: Total assets decreased from $34.06 million as of December 31, 2024, to $24.17 million as of September 30, 2025. This reduction is largely due to 'current assets held for sale' decreasing from $10.82 million to $5,000, indicating the sale of significant operational assets.
• Increased Current Debt [medium — financial]: Current debt has increased substantially from $1.26 million as of December 31, 2024, to $7.91 million as of September 30, 2025. This increase in short-term liabilities, coupled with low cash reserves, could strain liquidity.

Industry Context

AquaBounty Technologies operates in the aquaculture sector, specifically focusing on genetically engineered salmon. The industry is characterized by increasing demand for sustainable protein sources and growing interest in alternative farming methods. However, it faces challenges related to regulatory approvals, public perception of genetically modified organisms (GMOs), and competition from traditional aquaculture and other protein providers.

Regulatory Implications

The company's operations, particularly those involving genetically engineered organisms, are subject to stringent regulatory oversight in various jurisdictions. Changes in regulations or delays in approvals could significantly impact its ability to commercialize its products and expand its operations. Compliance with evolving environmental and food safety standards is critical.

What Investors Should Do

1. Monitor progress on securing new investment or strategic options for the Ohio Farm Project assets, as this is critical for addressing the going concern uncertainty.
2. Evaluate the company's ability to generate sustainable revenue and achieve profitability, given the continued negligible revenue and significant operating losses.
3. Assess the impact of the increased current debt ($7.91 million) on the company's liquidity, especially in light of its low cash position ($951,434).
4. Analyze the long-term viability of the business model, considering the substantial cumulative losses ($374 million) and the reliance on asset sales for cash generation.

Key Dates

• 2025-09-30: End of Q3 2025 — Reported a net loss of $1.38 million, an improvement from $3.40 million in Q3 2024. Cash and cash equivalents stood at $951,434.
• 2025-03-XX: Sale of Canadian Farms — Contributed to the $7.11 million in asset sale proceeds received year-to-date, bolstering cash reserves.
• 2024-07-XX: Sale of Indiana Farm — Contributed to the $7.11 million in asset sale proceeds received year-to-date, bolstering cash reserves.
• 2025-09-30: Balance Sheet Date — Total assets decreased to $24.17 million from $34.06 million at year-end 2024, primarily due to asset sales. Current debt increased significantly.

Glossary

Accumulated deficit

The total net losses of a company since its inception that have not been offset by net income. (Indicates the company's long-standing history of unprofitability, with a cumulative deficit of $374.1 million as of September 30, 2025.)

Current assets held for sale

Assets that a company intends to sell or dispose of within one year. (This category significantly decreased from $10.8 million to $5,000, reflecting the sale of major assets like the Indiana and Canadian Farms.)

Current liabilities held for sale

Liabilities directly associated with assets classified as held for sale. (This category also decreased significantly, aligning with the disposal of related assets.)

Loan forgiveness

The cancellation of a debt by the lender. (A $2.01 million loan forgiveness contributed to the reduced net loss for the nine months ended September 30, 2025.)

Asset impairment, net

A reduction in the carrying value of an asset when its recoverable amount falls below its book value. (While significantly lower than the prior year ($1.29 million in YTD 2025 vs. $26.26 million in YTD 2024), it still represents a cost impacting profitability.)

Discontinued operations

A component of a business that the company has disposed of or classified as held for sale, and that represents a separate major line of business or geographical area of operations. (The company reported a loss from discontinued operations of $90,197 for the nine months ended September 30, 2025, indicating ongoing wind-down activities.)

Year-Over-Year Comparison

Compared to the prior year's nine-month period, AquaBounty Technologies has significantly reduced its net loss from $65.08 million to $4.35 million. This improvement is largely attributable to a $2.01 million loan forgiveness and substantially lower asset impairment charges ($1.29 million in 2025 vs. $26.26 million in 2024). Total costs and expenses for the nine months also decreased from $33.7 million to $6.04 million. However, revenue remains negligible, and the company continues to face a going concern uncertainty, with total assets declining due to asset sales.

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share AQB The NASDAQ Stock Mark

Filing Documents

• aqb-20250930x10q.htm (10-Q) — 2529KB
• aqb-20250930xex31_1.htm (EX-31.1) — 14KB
• aqb-20250930xex32_1.htm (EX-32.1) — 8KB
• 0001603978-25-000069.txt ( ) — 9603KB
• aqb-20250930.xsd (EX-101.SCH) — 37KB
• aqb-20250930_cal.xml (EX-101.CAL) — 58KB
• aqb-20250930_def.xml (EX-101.DEF) — 140KB
• aqb-20250930_lab.xml (EX-101.LAB) — 411KB
• aqb-20250930_pre.xml (EX-101.PRE) — 304KB
• aqb-20250930x10q_htm.xml (XML) — 2290KB

Financial Statements

Financial Statements 2 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 15 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 20 Item 4.

Controls and Procedures

Controls and Procedures 20 PART II OTHER INFORMATION Item 1.

Legal Proceedings

Legal Proceedings 20 Item 1A.

Risk Factors

Risk Factors 21 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 22 Item 3. Defaults Upon Senior Securities 22 Item 4. Mine Safety Disclosures 22 Item 5. Other Information 22 Item 6. Exhibits 24

Signatures

Signatures 25 Cautionary Note Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q of AquaBounty Technologies, Inc. ("AquaBounty," the "Company," "we," "us" or "our") contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, that involve significant risks and uncertainties about AquaBounty. All statements other than statements of historical fact are forward-looking statements, and AquaBounty may use words such as "expect," "anticipate," "project," "intend," "plan," "aim," "believe," "seek," "estimate," "can," "focus," "will," and "may," similar expressions and the negative forms of such expressions to identify such forward-looking statements. We have based these forward-looking statements on our current expectations, assumptions, estimates, and projections. While we believe these expectations, assumptions, estimates, and projections are reasonable, such forward-looking statements are only predictions and involve known and unknown risks, uncertainties, and other factors, many of which are outside of our control, which could cause our actual results, performance, or achievements to differ materially from any results, performance, or achievements expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: our history of net losses and the likelihood of future net losses; our ability to continue as a going concern; our ability to raise additional funds, including from the sale of non-current assets, in sufficient amounts on a timely basis, on acceptable terms, or at all; our ability to retain and reengage key vendors and engage additional vendors, as needed; our ability to obtain approvals and permits to construct and operate our farms without delay; our ability to finance our Ohio Farm Project (as defined below) through the placement of municipal bonds, which may require restrictive debt covenants that could limit our co

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements AquaBounty Technologies, Inc. Condensed Consolidated Balance Sheets (Unaudited) As of September 30, 2025 December 31, 2024 Assets Current assets: Cash and cash equivalents $ 951,434 $ 230,362 Prepaid expenses and other current assets 519,027 292,018 Current assets held for sale 5,000 10,819,909 Total current assets 1,475,461 11,342,289 Property, plant and equipment, net 22,668,000 22,668,000 Right of use assets, net 30,330 51,509 Total assets $ 24,173,791 $ 34,061,798 Liabilities and stockholders' equity Current liabilities: Accounts payable and accrued liabilities $ 3,069,766 $ 10,104,853 Accrued employee compensation 914,067 977,088 Current debt 7,910,684 1,261,039 Other current liabilities 30,330 28,527 Current liabilities held for sale 8,741 3,830,041 Total current liabilities 11,933,588 16,201,548 Long-term lease obligations — 22,982 Long-term debt, net — 1,996,558 Total liabilities 11,933,588 18,221,088 Commitments and contingencies (Note 11) Stockholders' equity: Common stock, $ 0.001 par value, 75,000,000 shares authorized; 3,877,695 and 3,865,778 shares outstanding at September 30, 2025 and December 31, 2024, respectively 3,878 3,866 Additional paid-in capital 386,361,538 386,297,611 Accumulated other comprehensive loss — ( 688,229 ) Accumulated deficit ( 374,125,213 ) ( 369,772,538 ) Total stockholders' equity 12,240,203 15,840,710 Total liabilities and stockholders' equity $ 24,173,791 $ 34,061,798 See accompanying notes to these condensed consolidated financial statements. 2 AquaBounty Technologies, Inc. Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Costs and expenses Sales and marketing $ — $ 44,1

View Full Filing

View this 10-Q filing on SEC EDGAR